Cargando…

A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype

BACKGROUND: Imprinting centre 2 (IC2) in the chromosomal region 11p15.5 regulates the monoallelic expression of imprinted genes by differential methylation of paternal and maternal chromosomes. Copy number variants in IC2 are associated with Beckwith-Wiedemann syndrome and Silver-Russell syndrome (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudet, Marie Véronique, Allain, Eric Pierre, Gallant, Lynne M, Arts, Heleen H, Ben Amor, Mouna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887386/
https://www.ncbi.nlm.nih.gov/pubmed/35772847
http://dx.doi.org/10.1136/jmedgenet-2021-108288
_version_ 1784880331791269888
author Gaudet, Marie Véronique
Allain, Eric Pierre
Gallant, Lynne M
Arts, Heleen H
Ben Amor, Mouna
author_facet Gaudet, Marie Véronique
Allain, Eric Pierre
Gallant, Lynne M
Arts, Heleen H
Ben Amor, Mouna
author_sort Gaudet, Marie Véronique
collection PubMed
description BACKGROUND: Imprinting centre 2 (IC2) in the chromosomal region 11p15.5 regulates the monoallelic expression of imprinted genes by differential methylation of paternal and maternal chromosomes. Copy number variants in IC2 are associated with Beckwith-Wiedemann syndrome and Silver-Russell syndrome (SRS). Clinical outcome of IC2 deletions seems to depend on the parental origin of the chromosome, deletion size and inclusion or exclusion of enhancer and promoter regions. RESULTS: A paternally inherited 132 bp deletion within the KCNQ1OT1 gene was found in a proband with an SRS clinical phenotype. The patient’s father and paternal grandmother, who both carry the deletion on their maternal chromosome, are unaffected. Review of other IC2 deletions and their associated clinical presentation was useful in understanding the genetic–phenotypic correlation. CONCLUSION: Only six cases have been reported with deletions involving exclusively IC2, one being identical to our proband’s 132 bp deletion. Our study, which is based on more extensive segregation data than the previous 132 bp deletion report, confirms the association of this deletion with growth restriction when paternally inherited. Remarkably, even though our patient has the same deletion, he has more pronounced phenotypic features; our findings thus suggest that some degree of clinical variability may be associated with this loss.
format Online
Article
Text
id pubmed-9887386
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98873862023-02-01 A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype Gaudet, Marie Véronique Allain, Eric Pierre Gallant, Lynne M Arts, Heleen H Ben Amor, Mouna J Med Genet Epigenetics BACKGROUND: Imprinting centre 2 (IC2) in the chromosomal region 11p15.5 regulates the monoallelic expression of imprinted genes by differential methylation of paternal and maternal chromosomes. Copy number variants in IC2 are associated with Beckwith-Wiedemann syndrome and Silver-Russell syndrome (SRS). Clinical outcome of IC2 deletions seems to depend on the parental origin of the chromosome, deletion size and inclusion or exclusion of enhancer and promoter regions. RESULTS: A paternally inherited 132 bp deletion within the KCNQ1OT1 gene was found in a proband with an SRS clinical phenotype. The patient’s father and paternal grandmother, who both carry the deletion on their maternal chromosome, are unaffected. Review of other IC2 deletions and their associated clinical presentation was useful in understanding the genetic–phenotypic correlation. CONCLUSION: Only six cases have been reported with deletions involving exclusively IC2, one being identical to our proband’s 132 bp deletion. Our study, which is based on more extensive segregation data than the previous 132 bp deletion report, confirms the association of this deletion with growth restriction when paternally inherited. Remarkably, even though our patient has the same deletion, he has more pronounced phenotypic features; our findings thus suggest that some degree of clinical variability may be associated with this loss. BMJ Publishing Group 2023-02 2022-06-30 /pmc/articles/PMC9887386/ /pubmed/35772847 http://dx.doi.org/10.1136/jmedgenet-2021-108288 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epigenetics
Gaudet, Marie Véronique
Allain, Eric Pierre
Gallant, Lynne M
Arts, Heleen H
Ben Amor, Mouna
A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title_full A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title_fullStr A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title_full_unstemmed A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title_short A 132 bp deletion affecting the KCNQ1OT1 gene associated with Silver-Russell syndrome clinical phenotype
title_sort 132 bp deletion affecting the kcnq1ot1 gene associated with silver-russell syndrome clinical phenotype
topic Epigenetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887386/
https://www.ncbi.nlm.nih.gov/pubmed/35772847
http://dx.doi.org/10.1136/jmedgenet-2021-108288
work_keys_str_mv AT gaudetmarieveronique a132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT allainericpierre a132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT gallantlynnem a132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT artsheleenh a132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT benamormouna a132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT gaudetmarieveronique 132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT allainericpierre 132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT gallantlynnem 132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT artsheleenh 132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype
AT benamormouna 132bpdeletionaffectingthekcnq1ot1geneassociatedwithsilverrussellsyndromeclinicalphenotype